In conclusion, we demonstrated that lovastatin exhibits anti‐tumour activities via LKB1‐AMPK‐p38MAPK‐p53‐survivin cascade in luminal MCF‐7 breast cancer cells. This evidence concerns the gene TP53 and neoplasm.